Performance of RMD ResMed | -8.6% in 12m
Compare RMD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare ResMed with its related Sector/Index XLV
Performance Duell RMD vs XLV
TimeFrame | RMD | XLV |
---|---|---|
1 Day | 18.9% | 0.03% |
1 Week | 20.9% | 0.34% |
1 Month | 10.1% | -5.26% |
3 Months | 14.3% | 0.15% |
6 Months | 62.9% | 14.58% |
12 Months | -8.57% | 6.54% |
YTD | 27.3% | 1.21% |
Rel. Perf. 1m | 0.74 | |
Rel. Perf. 3m | 1.35 | |
Rel. Perf. 6m | 2.46 | |
Rel. Perf. 12m | -1.78 |
Is ResMed a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, ResMed (NYSE:RMD) is currently (April 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 76.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of April 2024 is 204.28. This means that RMD is currently overvalued and has a potential downside of -6.32% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of April 2024 is 204.28. This means that RMD is currently overvalued and has a potential downside of -6.32% (Sold with Premium).
Is RMD a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 0
Values above 0%: RMD is performing better - Values below 0%: RMD is underperforming
Compare RMD with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 19.20% | 12.94% | 38.22% | -32.54% |
US NASDAQ 100 | QQQ | 18.00% | 13.04% | 37.57% | -43.08% |
US Dow Jones Industrial 30 | DIA | 20.93% | 13.94% | 43.84% | -22.84% |
German DAX 40 | DBXD | 19.27% | 12.00% | 39.46% | -21.96% |
UK FTSE 100 | ISFU | 18.42% | 9.08% | 46.56% | -15.02% |
Shanghai Shenzhen CSI 300 | CSI 300 | 19.46% | 8.24% | 60.97% | 5.31% |
Hongkong Hang Seng | HSI | 14.31% | 7.34% | 65.40% | 11.51% |
Japan Nikkei 225 | EXX7 | 21.22% | 18.32% | 45.93% | -26.14% |
India NIFTY 50 | INDA | 20.08% | 8.69% | 41.08% | -36.05% |
Brasil Bovespa | EWZ | 19.20% | 12.82% | 53.75% | -26.95% |
RMD ResMed vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 20.24% | 12.01% | 35.24% | -43.56% |
Consumer Discretionary | XLY | 17.74% | 14.45% | 44.81% | -28.47% |
Consumer Staples | XLP | 20.32% | 11.12% | 47.63% | -9.04% |
Energy | XLE | 20.75% | 8.70% | 47.73% | -24.92% |
Financial | XLF | 21.03% | 13.20% | 31.95% | -33.83% |
Health Care | XLV | 20.57% | 15.37% | 48.29% | -15.11% |
Industrial | XLI | 19.86% | 12.73% | 34.59% | -33.29% |
Materials | XLB | 20.38% | 13.74% | 42.16% | -21.99% |
Real Estate | XLRE | 20.11% | 17.88% | 48.19% | -8.60% |
Technology | XLK | 18.04% | 14.16% | 38.37% | -42.13% |
Utilities | XLU | 20.67% | 9.29% | 48.17% | -7.83% |
Aerospace & Defense | XAR | 18.47% | 13.24% | 41.19% | -28.14% |
Biotech | XBI | 21.22% | 22.12% | 32.64% | -12.69% |
Homebuilder | XHB | 18.15% | 17.16% | 13.70% | -56.04% |
Retail | XRT | 18.46% | 17.41% | 35.60% | -29.49% |
Does ResMed outperform its market, is RMD a Sector Leader?
No, over the last 12 months ResMed (RMD) made -8.57%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.54%.
Over the last 3 months RMD made 14.32%, while XLV made 0.15%.
No, over the last 12 months ResMed (RMD) made -8.57%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.54%.
Over the last 3 months RMD made 14.32%, while XLV made 0.15%.
Period | RMD | XLV | S&P 500 |
---|---|---|---|
1 Month | 10.11% | -5.26% | -2.83% |
3 Months | 14.32% | 0.15% | 3.78% |
12 Months | -8.57% | 6.54% | 23.97% |